Search results
What You Can Learn From Oak Street Health, Inc.'s (NYSE:OSH) P/S
Simply Wall St. via Yahoo Finance· 1 year agoWhen close to half the companies in the Healthcare industry in the United States have price-to-sales...
Oak Street Health, Inc. (OSH) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Oak Street Health, Inc. (NYSE: OSH)Q2 2022 Earnings CallAug 03, 2022,...
Stock To Watch: Could CVS’s Acquisition of Oak Street Health Boost Shareholder Revenue?
GOBankingRates via Yahoo Finance· 1 year agoCVS announced it acquired Oak Street Health in an all-cash $10.6 billion deal, following similar...
Oak Street Health Full Year 2022 Earnings: EPS Misses Expectations
Simply Wall St. via Yahoo Finance· 1 year agoOak Street Health (NYSE:OSH) Full Year 2022 Results Key Financial Results Revenue: US$2.16b (up 51%...
Stark County business roundup: Oak Street Health opens center in Canton
The Repository via Yahoo Finance· 8 months agoCANTON − Oak Street Health, which provides primary care for adults on Medicare, has opened its first...
Time to Buy CVS or Oak Street Health Stock on Potential Acquisition?
Zacks via Yahoo Finance· 1 year agoNews of CVS Health (CVS) potentially acquiring Oak Street Health (OHS) for $10 billion broke this...
Oak Street Health, Inc. (OSH) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoOak Street Health, Inc. (OSH) delivered earnings and revenue surprises of 11.11% and 1%,...
CVS nearing $10.5 billion deal for primary-care provider Oak Street Health - WSJ
Reuters via Yahoo Finance· 1 year agoOak Street Health and CVS declined to comment on the report when contacted by Reuters. Bloomberg...
Why Shares of Oak Street Health Soared This Week
Motley Fool· 1 year agoShares of Oak Street Health (NYSE: OSH) were up 32.6% for the week, as of Thursday afternoon, according to data provided by S&P Global Market...
Here's Why You Should Retain CVS Health (CVS) Stock for Now
Zacks via Yahoo Finance· 4 months agoCVS Health Corporation CVS is well-poised for growth, backed by its consistently strong sales...